1. Home
  2. CTKB vs BBNX Comparison

CTKB vs BBNX Comparison

Compare CTKB & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

N/A

Current Price

$4.89

Market Cap

541.1M

Sector

Health Care

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$20.20

Market Cap

493.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTKB
BBNX
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
493.1M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
CTKB
BBNX
Price
$4.89
$20.20
Analyst Decision
Hold
Strong Buy
Analyst Count
4
10
Target Price
$5.63
$23.80
AVG Volume (30 Days)
764.1K
977.3K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
78.95
EPS
N/A
N/A
Revenue
$193,015,000.00
$100,251,000.00
Revenue This Year
$5.42
$34.90
Revenue Next Year
$7.03
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
17.67
53.94
52 Week Low
$3.28
$8.80
52 Week High
$6.18
$32.71

Technical Indicators

Market Signals
Indicator
CTKB
BBNX
Relative Strength Index (RSI) 58.91 56.57
Support Level $4.17 $9.34
Resistance Level $5.24 $20.48
Average True Range (ATR) 0.20 1.25
MACD 0.01 -0.31
Stochastic Oscillator 75.93 78.81

Price Performance

Historical Comparison
CTKB
BBNX

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: